Il Mondo · Internazionale

Perché i farmaci negli Stati Uniti costano di più. La crisi del calcio italiano è lo specchio del paese.

·28 min·2 clips
Trump threatens 100% tariffs on patented drugs, potentially doubling prices for treatments with no alternatives.
1. Internazionale's podcast presents a current-affairs roundup featuring two main analytical segments and a book recommendation. 2. The first segment features Giuseppe Traversa, described as an epidemiologist and author of Il valore dei farmaci published by Pensiero Scientifico; the second features Luca Pisapia, journalist and author of Calcio e Potere: una storia critica del mondiale da Mussolini a Trump, due from Einaudi on May 19. 3. The episode's first question is whether Trump's proposed 100% tariffs on pharmaceutical companies can actually reduce US drug prices. 4. Traversa explains that the US pharmaceutical market represents approximately 40% of global drug revenues, making access to it commercially essential for multinational companies. 5. He notes that a 100% tariff on a patented drug with no therapeutic alternatives simply doubles the price for end consumers, insurance companies, and ultimately patients — it does not reduce prices. 6. The core difference between US and European drug pricing is European national health service negotiation: each country's equivalent of Italy's AIFA assesses the therapeutic value added by a new drug over existing alternatives, then negotiates a reimbursement price accordingly. 7. Traversa uses semaglutide and tirzepatide — obesity and diabetes drugs — as his key example: the nominal price is 300-500 euros per month, but AIFA negotiated the Italian reimbursement price for diabetic patients to just over 3 euros per day, roughly 100 euros per month, fully covered by the national health service. 8. He notes that when patented drugs lose their patent protection, prices fall by 80-90 percent, sometimes 95 percent — which proves, he says, that pre-patent prices were never reflective of production costs but of monopoly pricing power. 9. Trump's argument that European countries pay too little for drugs is dismissed by Traversa as incoherent: European negotiated prices are profitable and cover R&D costs; US companies simply earn higher margins. 10. Traversa concludes that European patients are unlikely to see major price increases if health agencies like AIFA maintain their mandate to reimburse only drugs that add genuine therapeutic value at negotiated prices. 11. The second segment opens with a clip of Italian goalkeeper Gianluigi Donnarumma failing to save a decisive penalty against Bosnia at Zenica on March 31 — Italy's third consecutive World Cup qualification failure. 12. Pisapia places the defeats in sequence: Sweden eliminated Italy before Russia 2018, North Macedonia before Qatar 2022, and now Bosnia before the 2026 World Cup in Canada, the United States, and Mexico. 13. He argues that the players' frightened, self-enclosed body language at Zenica mirrored the economic situation of their generation: Italian 20-to-30-year-olds whose real wages grew only 2 percentage points over 30 years while the European average rose over 30 percent. 14. Pisapia cites FIGC's 2024 Calcio report, which shows Italian football's total production value is 4.5 billion euros against costs of 5.1 billion euros — a structural deficit of 0.7 billion — plus debts of 5.5 billion, of which 4.7 billion are attributable to Serie A alone. 15. He argues that calling for dismissals — of FIGC president Gravina, delegation chief Buffon, and coach Gattuso, all of whom resigned after the elimination — is as ineffective as a government cleaning up a 30-year systemic crisis by sacking a few ministers. 16. Pisapia notes that Italy's Under-21 team won 4-0 against Sweden days before the senior team's elimination, and praises the contribution of second-generation Italian players who are finally, he says with 'extreme delay,' appearing in national squads. 17. He argues that restrictive citizenship laws (Italy lacks ius soli) have denied the national team talents: players like Kylian Mbappé in France, Bukayo Saka in England, and Lamine Yamal in Spain — all children of immigrant parents — would have been ineligible for Italy until age 18 or later due to bureaucratic delays. 18. Pisapia closes by proposing that Italian sports fans redirect attention from a broken professional football system to other sports where Italy is succeeding — tennis, cycling, athletics, and women's basketball and volleyball — and to the growing movimento di calcio popolare, grassroots community football clubs prioritizing solidarity over profit. 19. The episode's tone is analytical and journalistic, with two back-to-back expert interviews structured around current news pegs: the Trump tariff announcement and the football elimination; the book recommendation segment is a one-paragraph audio editorial. 20. Best suited for listeners interested in Italian politics, public health economics, football sociology, or current affairs; not for those seeking optimistic sports coverage or detailed match analysis.
Listen to the show on